1X10^6 human PBMCs were surface stained with 0.2 ug Anti-Human CD5 (65200-1-Ig, Clone:L17F12) with CoraLite®594-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L) at dilution 1:1000 or unstained. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 0.2 ug Anti-Human CD5 (65200-1-Ig, Clone:L17F12) with CoraLite®594-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L) at dilution 1:1000 or unstained. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with FITC Anti-Human CD19 and 5 ul Atlantic Blue™ Anti-Human CD5 (AB-65200, Clone: L17F12) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Atlantic Blue™ Anti-Human CD5 (AB-65200, Clone:L17F12) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with APC Anti-Human CD19 and 5 ul Cardinal Red™ Anti-Human CD5 (CR-65200, Clone:L17F12) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul Cardinal Red™ Anti-Human CD5 (CR-65200, Clone:L17F12) (red) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite®405 Anti-Human CD5 (CL405-65200, Clone: L17F12) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite®405 Anti-Human CD5 (CL405-65200, Clone: L17F12) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 488 Anti-Human CD5 (CL488-65200, Clone:L17F12), or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 488 Anti-Human CD5 (CL488-65200, Clone:L17F12), or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with APC Anti-Human CD19 and 5 ul CoraLite® Plus 555 Anti-Human CD5 (CL555-65200, Clone:L17F12) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 555 Anti-Human CD5 (CL555-65200, Clone:L17F12) (red) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human peripheral blood lymphocytes were surface stained with 5 ul CoraLite® Plus 647-conjugated Anti-Human CD5 (CL647-65200, Clone: L17F12) (blue) or isotype control antibody (black). Cells were not fixed.

---

1X10^6 human PBMCs were surface co-stained with FITC Anti-Human CD19 and 5 ul CoraLite®750 Anti-Human CD5 (CL750-65200, Clone:L17F12) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite®750 Anti-Human CD5 (CL750-65200, Clone:L17F12) or Mouse IgG2a Isotype Control. Cells were not fixed. Lymphocytes were gated.

---